Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

German airline Lufthansa's air freight business said on Friday it is experiencing an increase in demand for pharmaceutical ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

AG Kwame Raoul files for approval of a $39.1 million settlement with Apotex Inc. over drug price inflation claims.

Billionaire investor and entrepreneur Mark Cuban is taking strides to overhaul the U.S. healthcare sector, beginning with his ...

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...